nanoTox™: Risk assessment and risk management exclusively for nanoparticles

nanoTox is the first company to provide complete risk assessment – and solutions – exclusively for nanoparticles. nanoTox evaluates the safety of its clients’ nanotechnology-enabled products through toxicity evaluations and offers strategies for managing, reducing or eliminating risk to meet regulatory requirements and shorten time to market.

Recognized data quality standards

nanoTox assessments are based on recognized U.S., E.U. and international toxicological data quality standards and state-of-the-science methods, so its results can be used in court and its risk data are accepted by the insurance industry. This also is vital for venture capital firms that need to ensure their nanoproduct investments will be marketable and for law firms employed to defend nanotech companies against liability claims.

Confidentiality assured

GLP laboratory facilities, instruments, data systems, personnel and associated procedures also are designed to ensure complete client confidentiality and intellectual property protection. This privacy extends to all nanoTox clients, including companies or entities that require regulatory approval to market their nanoproducts, venture capital firms that invest in nanoproduct companies, law firms engaged by such companies and insurance companies considering insuring such companies from liability.

Fast, cost-effective evaluation

With GLP facilities, personnel and supporting laboratories worldwide, nanoTox™ provides unique, time-efficient and cost-effective safety evaluation platforms and product development support programs that are essential for safe nanoproduct research, production, design, development, use and disposal.

nanoTox is an operating subsidiary of Nano Risk Assessment, Inc.

Government regulations demanding more nanomaterial data:

As companies employing nanotechnology particles in their products prepare for market, they face changing government policies and new regulations in the coming year, as officials and the public weigh in on how to best evaluate these potential products for safety. For information on new regulatory policies being considered by governments throughout the world, see “Nanotechnology and the U.S. regulatory environment.” Learn more.